UK Clinical Research Vision To Drive Novel Trial Design
Executive Summary
A pilot conducted by the UK medicines agency to improve patient involvement in research will support newly announced plans to improve clinical research.
You may also be interested in...
Regulators Call for More Harmonization On Ultra-Rare ATMPs
Early discussions between companies and multiple regulators could drive greater alignment among jurisdictions.
Can The UK Remain A First Launch Market?
More pollical support from the National Health Service and health ministers is needed to ensure the UK’s future as a desirable launch market.
Gilead’s Trodelvy To Test UK Innovative Drug Pathway
The cancer drug is also to undergo an accelerated assessment by the European Medicines Agency.